Tango Therapeutics (TNGX) Amortizatization of Intangibles (2023 - 2026)

Tango Therapeutics' (TNGX) quarterly Amortizatization of Intangibles came in at -$1.1 million in Q1 2026, down 76.18% year-on-year from -$4.7 million in Q1 2025, and down 46.35% quarter-over-quarter from -$768000.0 in Q4 2025.

Tango Therapeutics (TNGX) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends

Tango Therapeutics' Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at -$1.1 million for Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles fell 76.18% year-over-year to -$1.1 million in Q1 2026; TTM through Mar 2026 was -$3.2 million, a 18.28% increase from a year earlier, with the FY2025 full-year figure at -$2.7 million, up 41.78% from the prior year.
  • Amortizatization of Intangibles retreated to -$1.1 million in Q1 2026 per TNGX's latest filing, from -$768000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $739000.0 in Q3 2023 and bottomed at -$2.4 million in Q4 2023.
  • The 4-year median for Amortizatization of Intangibles is -$876000.0 (2023), against an average of -$909461.5.
  • Biggest YoY gain for Amortizatization of Intangibles was 63.79% in 2024; the steepest drop was 260.49% in 2024.
  • Year by year, Amortizatization of Intangibles stood at -$2.4 million in 2023, then jumped by 63.79% to -$856000.0 in 2024, then advanced by 10.28% to -$768000.0 in 2025, then tumbled by 46.35% to -$1.1 million in 2026.
  • Per Business Quant, the three latest TNGX Amortizatization of Intangibles figures stand at -$1.1 million (Q1 2026), -$768000.0 (Q4 2025), and -$560000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Tango Therapeutics 3.86 Bn 3.70 Bn - -1.12 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.12 Mn
Mar 31, 2026 -1.12 Mn
Dec 31, 2025 -768,000.00
Dec 31, 2025 -768,000.00
Sep 30, 2025 -560,000.00
Sep 30, 2025 -560,000.00
Jun 30, 2025 -722,000.00
Jun 30, 2025 -722,000.00
Mar 31, 2025 -638,000.00
Mar 31, 2025 -638,000.00
Dec 31, 2024 -856,000.00
Dec 31, 2024 -856,000.00
Sep 30, 2024 -1.19 Mn
Sep 30, 2024 -1.19 Mn
Jun 30, 2024 -1.20 Mn
Jun 30, 2024 -1.20 Mn
Mar 31, 2024 -1.37 Mn
Mar 31, 2024 -1.37 Mn
Dec 31, 2023 -2.36 Mn
Dec 31, 2023 -2.36 Mn